Nathalie Risse
Directeur Financier/CFO chez GTP Technology SA
Directeur Financier/CFO chez GTP Technology SA
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
GTP Technology SA
 GTP Technology SA Pharmaceuticals: MajorHealth Technology GTP Technology SA provides tailor-made solutions for the engineering and expression of recombinant proteins. The company produces recombinant proteins for use either in high throughput screening, crystallography, biochemical or biological activity characterization or as protein antigen for antibody production and diagnostics. The firm provides its services to pharmaceutical, cosmetic, biotech, food and academic industries. GTP Technology was founded by Eric Devic in 2000 and is headquartered in Labège, France.
4
| Private Company | Pharmaceuticals: Major | 4 |
Relation dans plusieurs entreprises
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Université Fédérale Toulouse Midi-Pyrénées | College/University | Doctorate Degree | |
| Université de Montpellier | College/University | Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal | |
| Institut de Pharmacologie et de Biologie Structurale | College/University | Doctorate Degree | |
| Ecole Nationale Supérieure Agronomique de Montpellier | College/University | Doctorate Degree | |
Biopolis SL
 Biopolis SL Miscellaneous Commercial ServicesCommercial Services Biopolis SL engaged in the research and development services in the biotechnology industry. It offers solutions in the fields of agri-food biotechnology, microbial biotechnology, pharmaceuticals, cosmetics, energy, and technology platform. The company was founded in 2003 and is headquartered in Paterna, Spain. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Institut National des Sciences Appliquées de Lyon | College/University | Undergraduate Degree | |
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Miltenyi Biotec GmbH provides biotechnology products and services. The firm products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research. Its clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration and freezing products. The company was founded by Stefan Miltenyi in 1989 and is headquartered in Teterow, Germany. | Financial Conglomerates | Corporate Officer/Principal |
Internationale
| France | 6 |
| Etats-Unis | 3 |
| Espagne | 2 |
| Allemagne | 2 |
Sectorielle
| Consumer Services | 7 |
| Commercial Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 3 |
| Undergraduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chairman | 1 |
| Insiders | |
|---|---|
| Eric Devic | 4 |
| Séverine Hountondji | 4 |
| Nicolas Issaly | 3 |
| Hérvé Ginisty | 2 |
